Study: SGLT2 Inhibitors Promote Weight Loss More Than GLP-1 Receptor Agonists

Pharmacy TimesOctober 2021
Volume 87
Issue 10
Pages: 70

Individuals with type 2 diabetes (T2D) who were prescribed sodium-glucose cotransporter-2 (SGLT2) inhibitors lost significantly more weight than those who were prescribed glucagon-like peptide 1 (GLP-1) receptor agonists (RAs), according to the findings of a new study led by investigators at the University at Buffalo.

Investigators aimed to evaluate the differences in weight loss caused by GLP-1 RAs and SGLT2 inhibitors, both of which are frequently prescribed for T2D. Among 72 patients, individuals receiving SGLT2 inhibitors experienced a median weight loss of more than 6 lb, compared with a median of 2.5 lb among those receiving GLP-1 RAs.

Canagliflozin was the most commonly prescribed SGLT2 inhibitor, and liraglutide was the most commonly prescribed GLP-1 RA, according to the study results.

No significant differences were found in blood pressure, blood sugar levels, or kidney function after use of the medications.

The findings suggest that SGLT2 inhibitors may be more protective
against weight gain caused by other antidiabetic drugs than GLP-1 RAs, according to a statement.

The findings also go against earlier research, which showed that GLP-1 RAs are the superior antidiabetic drug for weight loss, according to the study authors.

They added that although the weight loss caused by the drug is small, the study results warrant larger investigations that examine the medications’ impact on weight.


Antidiabetic drug causes double the weight loss of competitor in type 2 diabetes patients. News release. University at Buffalo. July 1, 2021. Accessed July 6, 2021.

Related Videos
Image credit:  Gorodenkoff |
Pharmacist and Patient in Pharmacy | Image Credit: Gorodenkoff -
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin -
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny -
Various healthy foods -- Image credit: New Africa |
LGBTQIA+ pride -- Image credit: lazyllama |
Modern pharmacy building facade with large window showcasing the interior, as seen from the street view, promoting a welcoming atmosphere for customers. Frontal view. Generative AI - Image credit: Karrrtinki |
Close up hands of helping hands elderly home care. Mother and daughter. Mental health and elderly care concept - Image credit:  ipopba |
Ozempic, obesity, drug shortage, media portrayal | Image Credit: zimmytws -
© 2024 MJH Life Sciences

All rights reserved.